John Friend
Chief Executive Officer at KAZIA THERAPEUTICS LIMITED
Profile
John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.
John Friend active positions
Companies | Position | Start |
---|---|---|
KAZIA THERAPEUTICS LIMITED | Chief Executive Officer | 01/05/2023 |
Former positions of John Friend
Companies | Position | End |
---|---|---|
CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 02/11/2021 |
CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 27/11/2018 |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Chief Tech/Sci/R&D Officer | 01/04/2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Chief Tech/Sci/R&D Officer | - |
Training of John Friend
Southern Methodist University | Undergraduate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
KAZIA THERAPEUTICS LIMITED | Health Technology |
Private companies | 2 |
---|---|
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |
- Stock Market
- Insiders
- John Friend